Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze SMMT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SMMT investment potential.

What is SMMT stock price today?

Get real-time SMMT stock price, historical data, and price charts on Financhill. Track SMMT performance with our advanced analysis tools.

Is SMMT a good investment?

Evaluate SMMT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SMMT stock?

To buy SMMT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SMMT?

View detailed market capitalization data and company valuation metrics for SMMT on our comprehensive analysis page.

What is the P/E ratio of SMMT?

Use our fundamental analysis tools to view SMMT P/E ratio and compare valuation metrics with industry peers.

What are SMMT earnings?

View SMMT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Summit Therapeutics, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

SMMT
Summit Therapeutics, Inc.

Last Price:

$18.31

Seasonality Move:

26.83%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

Summit Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Summit Therapeutics, Inc. has on average historically risen by 101.6% based on the past 10 years of stock performance.
Summit Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Summit Therapeutics, Inc. Stock Undervalued?

The current Summit Therapeutics, Inc. [SMMT] share price is $18.31. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Summit Therapeutics, Inc. has on average historically risen by 101.6% based on the past 10 years of stock performance.

Summit Therapeutics, Inc. Stock Rating

Sell

Summit Therapeutics, Inc. (SMMT) is a Sell

Is Summit Therapeutics, Inc. overpriced?

Summit Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Summit Therapeutics, Inc. Stock Price History

Is SMMT stock going to rise?

The current trend is relatively stagnant and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

smmttx.com

52-Week Data

52-Week High:

36.91

52-Week Low:

15.55

Prediction Charts

Market Cap:

13.6B

Price in USD:

18.31

Volume:

2.4M

Beta:

-0.25

Technical Analysis

SMA50:

19.31

SMA100:

21.87

SMA200:

21.98

52-Wk Change:

4.51%

Stock Predictions

Is Summit Therapeutics, Inc. stock public?

Yes, Summit Therapeutics, Inc. is a publicly traded company.
What is the Summit Therapeutics, Inc. stock quote today?

The Summit Therapeutics, Inc. stock price is 18.31 USD today.
How to buy Summit Therapeutics, Inc. stock online?

You can buy Summit Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	17.77	16.95	18.00	16.93
Nov-18	16.71	16.81	17.18	16.45
Nov-19	16.80	16.56	17.02	16.32
Nov-20	16.86	16.45	17.25	15.88
Nov-21	16.40	16.19	16.58	15.62
Nov-24	16.23	17.84	17.95	16.23
Nov-25	17.80	17.64	17.98	17.21
Nov-26	17.70	17.82	18.00	17.46
Nov-28	18.02	17.89	18.17	17.66
Dec-1	17.55	17.26	17.83	17.25
Dec-2	17.19	17.25	17.54	16.76
Dec-3	17.39	18.37	19.05	17.32
Dec-4	18.29	18.81	18.99	18.19
Dec-5	18.88	18.31	19.10	18.08

Summit Therapeutics, Inc. Earnings

Summit Therapeutics, Inc. Earnings Report: Per Share Summit Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics, Inc. Forecast Revenue Growth

Summit Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and an increase next year of $0.03 per share.

* Summit Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.